Cargando…
Wilson’s disease: Prospective developments towards new therapies
Wilson’s disease (WD) is an autosomal recessive disorder of copper metabolism, caused by mutations in the ATP7B gene. A clear demand for novel WD treatment strategies has emerged. Although therapies using zinc salts and copper chelators can effectively cure WD, these drugs exhibit limitations in a s...
Autores principales: | Ranucci, Giusy, Polishchuck, Roman, Iorio, Raffaele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558108/ https://www.ncbi.nlm.nih.gov/pubmed/28852304 http://dx.doi.org/10.3748/wjg.v23.i30.5451 |
Ejemplares similares
-
Zinc monotherapy is effective in Wilson’s disease patients with mild liver disease diagnosed in childhood: a retrospective study
por: Ranucci, Giusy, et al.
Publicado: (2014) -
The Paradox of Copper Deficiency in Wilson's Disease Patients
por: Iorio, Raffaele, et al.
Publicado: (2023) -
Characterization of the most frequent ATP7B mutation causing Wilson disease in hepatocytes from patient induced pluripotent stem cells
por: Parisi, Silvia, et al.
Publicado: (2018) -
Author Correction: Characterization of the most frequent ATP7B mutation causing Wilson disease in hepatocytes from patient induced pluripotent stem cells
por: Parisi, Silvia, et al.
Publicado: (2020) -
Obese children with fatty liver: Between reality and disease mongering
por: Ranucci, Giusy, et al.
Publicado: (2017)